HLA-E and NKG2A Mediate Resistance to BCG Immunotherapy in Non-Muscle-Invasive Bladder Cancer.
Ranti D, Yu H, Salomé B, Bang S, Duquesne I, Wang YA, Bieber C, Strandgaard T, Merritt E, Doherty G, Narasimhan A, Okulate I, Houghton S, Hug B, Kim J, Ravichandran H, Demetriou A, Li Z, Lindskrog SV, da Silva ANMR, Ruan DF, Daza J, Ingles JC, Rai R, Hegewisch-Solloa E, Mace EM, Fernandez-Rodriguez R, Izadmehr S, Farkas AM, Cruz-Encarnacion P, Shroff S, Patel F, Tran M, Youssef D, Ananthanarayanan A, Park J, Geanon D, Kelly G, Lee B, Nie K, Miake-Lye S, Xie H, Chen R, Bi C, Rizakos T, Villagomez B, Thin TH, Garcia-Barros M, Brown H, Martin B, Mateo A, Soto A, Sussman R, Shiwlani S, Francisco-Simon S, Beaumont KG, Wang YC, Wang L, Sebra RP, Smith S, Skobe M, Clancy-Thompson E, Palmer D, Hammond S, Yolmo P, Koti M, Hopkins BD, Wiklund P, Zhu J, Bravo-Cordero JJ, Brody R, Chen Z, Kim-Schulze S, Dyrskjøt L, Elemento O, Tocheva A, Song WM, Bhardwaj N, Galsky MD, Sfakianos JP, Horowitz A.
Ranti D, et al. Among authors: hug b.
bioRxiv [Preprint]. 2025 Sep 9:2024.09.02.610816. doi: 10.1101/2024.09.02.610816.
bioRxiv. 2025.
PMID: 39282294
Free PMC article.
Preprint.